Evidence map›Paper›PMID 18835843›Full record

ReviewCardiovascular research2009

Macro- and micronutrient dyshomeostasis in the adverse structural remodelling of myocardium.

Karl T Weber, William B Weglicki, Robert U Simpson

Registry-linked trialAbstract readReview
In one paragraph

Review in Cardiovascular research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01182376 (SOAR), which is not on this map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01182376 phase3completednot on this mapstarted 2010, after this paper: background citation

SOAR: Study Observing Antiarrhythmic Remodelling Using LGE-MRI

TypeinterventionalSponsorUniversity of UtahRan2010 to 2012Enrolled33ConditionsAtrial FibrillationArmsdronedarone, Placebo
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Vitamin D-Parathyroid Hormone-Fibroblast Growth Factor 23 Axis and Cardiac Remodeling.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2025
    Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Zinc Deficiency as a Reversible Cause of Heart Failure.Texas Heart Institute journal · 2020
    Article
  16. Review
  17. Observational
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Karl T WeberDivision of Cardiovascular Diseases, University of Tennessee Health Science Center, 920 Madison Ave., Suite 300, Memphis, TN 38163, USA. ktweber@utmem.edu
William B Weglicki
Robert U Simpson

Funding

Cardiomyopathy:Pro-Oxidant Role of Zidovudine (AZT)R01HL065178 · NHLBI · GEORGE WASHINGTON UNIVERSITY · PI WEGLICKI, WILLIAM BERNARD · 2000 to 2007
$2.7M
SUBSTANCE P-MEDIATED CARDIOVASCULAR INFLAMMATIONR01HL062282 · NHLBI · GEORGE WASHINGTON UNIVERSITY · PI WEGLICKI, WILLIAM BERNARD · 2000 to 2007
$2.5M
Aldosteronism: An Immunostimulatory StateR01HL073043 · NHLBI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI WEBER, KARL T · 2004 to 2008
$1.8M
Vitamin D regulation of ECM in model of heart failureR01HL074894 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SIMPSON, ROBERT U. · 2004 to 2007
$1.2M
NHLBI NIH HHS R01-HL062282NHLBI NIH HHS R01-HL065178NHLBI NIH HHS R01-HL073043NHLBI NIH HHS R01-HL074894
6 · The paper itself

Abstract

Hypertension and heart failure are worldwide health problems of ever-increasing proportions. A failure of the heart, during either systolic and/or diastolic phases of the cardiac cycle, has its origins rooted in an adverse structural, biochemical, and molecular remodelling of myocardium that involves its cellular constituents, extracellular matrix, and intramural coronary vasculature. Herein we focus on the pathogenic role of a dyshomeostasis of several macro- (i.e. Ca(2+) and Mg(2+)) and micronutrients (i.e. Zn(2+), Se(2+), and vitamin D) in contributing to adverse remodelling of the myocardium and its failure as a pulsatile muscular pump. An improved understanding of how these macro- and micronutrients account for the causes and consequences of adverse myocardial remodelling carries with it the potential of identifying new biomarkers predictive of risk, onset and progression, and response to intervention(s), which could be monitored non-invasively and serially over time. Moreover, such incremental knowledge will serve as the underpinning to the development of novel strategies aimed at preventing and/or regressing the ongoing adverse remodelling of myocardium. The time is at hand to recognize the importance of macro- and micronutrient dyshomeostasis in the evaluation and management of hypertension and heart failure.

Indexed as

Ventricular RemodelingAnimalsBiomarkersCalciumCopperDisease ProgressionHeart FailureHomeostasisHumansHypertensionMagnesiumMicronutrientsMyocardiumPrognosisSeleniumVitamin DBiomarkersCalciumCopperMagnesiumMicronutrientsSeleniumVitamin DZinc

Identifiers

PMID18835843
PMCPMC2639130

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.